Kyla Gibboney specializes in complex civil litigation, with a particular focus on antitrust class actions. Representative matters include:
- Cipro Antitrust Litigation: The firm represents a class of California consumers and insurers who brought antitrust claims against Bayer Corporation, Barr Laboratories, and other generic drug companies, alleging that the companies paid drug manufacturers to delay the release of a Cipro alternative. Settlements totaling $399 million fully resolved Plaintiffs’ claims against Defendants;
- Facebook Content Moderators’ Safe Workplace Litigation: The Firm represents Plaintiff Selena Scola in a class action lawsuit against Facebook, Inc., and Pro Unlimited, Inc., alleging that content moderators responsible for viewing and removing offensive and extremely disturbing videos, images, and broadcasts from Facebook users are suffering from psychological trauma and post-traumatic stress disorder (“PTSD”), and are not being protected properly by the social media company;
- Generic Drug Price-Fixing Antitrust Litigation: The firm is on the Plaintiffs’ Steering Committee representing U.S. consumers and insurers in a multidistrict antitrust litigation accusing a large number of generic drug manufacturers with conspiring to fix and raise prices for 18 generic medications. In the past few years, prices for these drugs have skyrocketed by more than 1,000 percent. Consumers blame the companies for engineering these price hikes, eliminating the benefits of competition, and forcing them to pay exorbitant prices. The firm is also currently investigating many other generic drugs for potential class action claims;
- LG/Samsung Antitrust Litigation: The firm represents current and former LG and Samsung employees in a class action against the two electronics giants, alleging that they entered into an illegal no-poaching agreement that limits employee access to mobility and compensation; and
- Lidoderm Antitrust Litigation: The firm serves as Liaison Counsel for Lidoderm End-Payors in a class action lawsuit against Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Inc., and Actavis Inc., along with their respective subsidiaries. The suit alleges that the companies entered into an illegal reverse payment agreement, forcing companies and consumers to pay higher prices for the Lidocaine-based pain patch, Lidoderm. In February 2017, Judge William H. Orrick granted the End-Payor Plaintiffs’ motion for class certification.
In 2018, Kyla was named a Northern California “Rising Star” by Thomson Reuters’ Super Lawyers publication.
During law school, Kyla served as a legal extern for the Antitrust Division of the Department of Justice, where she gained hands-on trial and regulatory experience. She completed judicial externships for Magistrate Judge Kandis A. Westmore of the Northern District of California and Justice Sandra L. Margulies of the California Court of Appeal for the First District. She was also active in the pro bono community and served as the Executive Articles Editor of the Hastings Constitutional Law Quarterly.